MedTech Spectrum

Article Name Medical Devices

Medtronic Evolut™ TAVR Platform Outperforms Surgery, Sustained Valve Performance for Low-Risk Patients at Four Years

TCT 2023: Medtronic adds to the body of evidence for Evolut TAVR with late-breaking clinical trial data from the Evolut Low Risk Trial

26th October, 2023

Boston Scientific's AGENT™ Drug-Coated Balloon Outperforms Uncoated Balloon in IDE Trial

Data from first coronary DCB study in U.S. meet 12-month primary endpoint, demonstrate low adverse event rates with AGENT DCB

26th October, 2023

Japan-based Shimadzu unveils integrated system for urine volume measurement

Measuring urine volume based on the difference in body weight before and after urination, eliminating the need for urine collection

26th October, 2023

JINGHAO MEDICAL's self-fitting OTC hearing aids received FDA 510(k) approval

As the first hearing aid manufacturer to be listed in China, JINGHAO MEDICAL has once again taken a historic step. On September 26, 2023, the self-fitting OTC hearing aid developed and manufactured by JINGHAO MEDICAL officially received FDA 510K approval.

24th October, 2023

Mindray Expands Cardiac Biomarker Portfolio with hs-cTnI and NT-proBNP Assays

Mindray, a global leader in medical devices and solutions, introduces new high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The additions have enhanced Mindray's diverse portfolio of cardiac biomarkers for diagnosing and managing cardiovascular diseases (CVDs).

24th October, 2023

Medtronic FDA Approved for Extravascular Defibrillator for Heart Rhythms

First-of-its-kind Aurora EV-ICD™ system offers single device, single procedure with lead placed outside of heart and veins

24th October, 2023

“Medtronic aims to foster collaboration with local ecosystem and stakeholders in Hyderabad”

In a significant move towards the growth of the healthcare technology sector in India, Ireland-headquartered Medtronic had announced an investment of approximately Rs 3000 crore, earlier this year, to expand the Medtronic Engineering & Innovation Center (MEIC) in Hyderabad. MEIC is Medtronic’s largest research and development (R&D) centre outside of the US. In addition, Medtronic is supporting the Government of Telangana’s efforts to position Hyderabad as a global hub for healthcare technology research and innovation. In conversation with MedTech Spectrum & BioSpectrum, Divya Prakash Joshi, Vice President & MEIC Site Leader, Medtronic talks about the new investment and the future plans of MEIC.

23rd October, 2023

Olympus Introduces New CPT Codes for iTind Procedure

Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer, and more fulfilling, announced that the American Medical Association (AMA) will issue two new Category I Current Procedural Terminology (CPT®) codes for the iTind™ procedure, a minimally invasive treatment for men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).

22nd October, 2023

Smith+Nephew Introduces REGENETEN◊ Implant for Rotator Cuff Tears in Japan

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce the launch of its REGENETEN Bioinductive Implant allowing access to thousands of patients in Japan. With more than 100,000 procedures completed globally since its introduction in the US and Europe, REGENETEN has had a transformative impact on the way surgeons approach rotator cuff repair.

20th October, 2023

SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement

SHL Medical ("SHL"), a world-leading solutions provider of advanced drug delivery systems such as autoinjectors and innovative specialty delivery systems, has entered into a non-exclusive co-marketing partnership agreement with Lifecore Biomedical (Nasdaq: LFCR) ("Lifecore"), a fully integrated Contract Development and Manufacturing Organization ("CDMO") that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials.

19th October, 2023

MiRus Receives FDA Clearance for MoRe® Low-Profile Spinal Plating Systems

MiRus® announced that it has received FDA 510(k) clearance of the CYGNUS™ MoRe® Anterior Cervical Plate and MiRus® 3DR™ Lateral Lumbar Interbody Fusion System with Integrated MoRe® plate fixation, both being the narrowest and thinnest plating system amongst all plates on the global spine market.

19th October, 2023

Oneview Healthcare and Baxter Announce Connected Care Collaboration During Meeting with Enterprise Ireland

Oneview Healthcare (Oneview), a leading provider of patient experience solutions, and Baxter International Inc. (Baxter), a global medtech leader, are pleased to announce the official launch of their strategic relationship in the United States. The launch was announced during a joint meeting at Baxter’s global headquarters in the Chicago attended by the Irish government Minister for Enterprise, Trade, and Employment, Simon Coveneyas part of Enterprise Ireland’s trade mission to Chicago.

19th October, 2023

Global Fund & Siemens Healthineers Boost Artificial Intelligence for Tuberculosis Diagnosis

Siemens Healthineers and the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), announced a partnership at the World Health Summit today to accelerate the use of artificial intelligence (AI) in diagnosing tuberculosis (TB), a preventable, treatable, and curable infectious disease that is again on the rise globally.

18th October, 2023

Baxter Introduces Digital Image Capture for PanOptic Plus Ophthalmoscope

Baxter International Inc. (NYSE:BAX), a leader in patient monitoring, physical assessment and vision screening products, announced the launch of digital image capture capability for eye exams using its existing Welch Allyn PanOptic Plus Ophthalmoscope. The iExaminer Pro System adds a key technology to routine eye exams, designed to help advance healthcare professionals’ ability to examine and diagnose the eye health of patients.

17th October, 2023

GE Healthcare Gets FDA Clearance for Allia IGS Pulse: Next-Gen Cardiac Imaging System

GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the company’s image guided system (IGS) offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size.

17th October, 2023

Cordis Statement on CMS Expansion of Carotid Stenting Coverage

Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, strongly supports the decision made by the Centers for Medicare & Medicaid Services (CMS) to expand coverage of carotid artery stenting (CAS) cms.gov. This expansion in coverage will allow patients that suffer from carotid artery disease expanded access to minimally invasive endovascular carotid therapy.

17th October, 2023

Werfen Secures FDA 510(K) Clearance for Aptiva® Tissue Disease Reagent

New Reagent Aids in Diagnosis of Connective Tissue Disease in Hard-to-Diagnose Autoimmune Diseases, Reducing Time to Diagnosis and Improving Patient Outcomes

17th October, 2023

Shaping the Future of Anaesthesia and Critical Care in India: An Exclusive Interview with Shalin Patel, Managing Director of Draeger India Group

On the occasion of World Anaesthesia Day, MedTech Spectrum & BioSpectrum India delve into the dynamic world of healthcare and technological innovation. We had the privilege of speaking with Mr. Shalin Patel, the Managing Director of Draeger India Group, a prominent player in the medical and safety technology sector.

16th October, 2023